Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|March 27, 2023
Characterizing burnout among healthcare epidemiologists in the early phases of the COVID-19 pandemic: A study of the SHEA Research NetworkTucker John Guy Smith, Rachel Pryor, Susy S Hota, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled TrialSusy S Hota, Valerie Sales, George Tomlinson, et al.
Journal of the Pediatric Infectious Diseases Society|January 31, 2023
Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020Anada Silva, Tim Du, Kelly B Choi, et al.
Diabetes, Obesity & Metabolism|October 14, 2022
Effect of faecal microbial transplant via colonoscopy in patients with severe obesity and insulin resistance: A randomized double-blind, placebo-controlled Phase 2 trialYasaman Ghorbani, Katherine J P Schwenger, Divya Sharma, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Plasmid genomic epidemiology of <i>bla</i><sub>KPC</sub> carbapenemase-producing <i>Enterobacterales</i> in Canada, 2010-2021Nicole Lerminiaux, Robyn Mitchell, Jessica Bartoszko, et al.
Cell Reports. Medicine|May 17, 2023
Gut microbiome modified by bariatric surgery improves insulin sensitivity and correlates with increased brown fat activity and energy expenditureJitender Yadav, Tao Liang, Tairan Qin, et al.
JAMA Network Open|February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialEmily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
Trials|July 9, 2026
Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trialConnor Prosty, Alex Carignan, Adrienne K Chan, et al.
Antimicrobial Resistance and Infection Control|July 12, 2025
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023Robyn Mitchell, Laura Mataseje, Joëlle Cayen, et al.
Infection Control and Hospital Epidemiology|August 18, 2022
Trends in <i>Clostridioides difficile</i> infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemicKelly B Choi, Tim Du, Anada Silva, et al.
Pageof 3